All In Biotech

Free tool

FAERS Monitor: Faslodex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021344 or its brand name (Faslodex, Fulvestrant). Reports on generic versions are filed under their own applications.

Reports

33,513

Serious

27,136

81% of reports

Hospitalization

7,682

Death reported

5,028

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression4,341
  • fatigue4,249
  • nausea3,085
  • death2,782
  • diarrhoea2,684
  • neutropenia2,542
  • white blood cell count decreased2,247
  • metastases to bone2,179
  • neoplasm progression2,130
  • asthenia1,812
  • pain1,786
  • metastases to liver1,779
  • breast cancer metastatic1,696
  • dyspnoea1,654
  • vomiting1,605

Reports by year received

View as table
YearReports
200463
2005115
2006128
2007149
2008166
2009158
2010141
2011268
2012541
2013343
2014346
2015713
20161,522
20172,213
20182,278
20192,870
20203,607
20213,353
20223,238
20233,862
20242,760
20252,874
20261,805

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,646 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer metastaticSignal1,696117.6111.8165,068
metastases to boneSignal2,17995.991.8177,559
metastases to liverSignal1,77970.667.3109,747
neoplasm progressionSignal2,13040.939.277,919
malignant neoplasm progressionSignal4,34127.727.0107,635
white blood cell count decreasedSignal2,24713.312.725,069
neutropeniaSignal2,54211.911.525,151
fatigueSignal4,2493.43.37,586
astheniaSignal1,8123.02.92,502
diarrhoeaSignal2,6842.62.52,752
nauseaSignal3,0852.52.42,744
vomitingSignal1,6052.12.01,001
deathSignal2,7822.02.01,510
dyspnoea1,6541.81.8644
pain1,7861.81.7686

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.